Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

Elusys Announces Results from Anthrax Anti-Toxin Trials

GlobalBiodefense- Elusys Therapeutics, Inc. this week announced it has completed three Phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204), an anti-toxin in development for the treatment of inhalation anthrax. Data from these studies support the safety and tolerability of the antitoxin when administered intravenously (IV) at the intended therapeutic  Read More »

Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies)

Ebola virus disease currently has no vaccines or medicines approved by national regulatory authorities for use in humans save for the purpose of compassionate care. To date, the virus has infected 6242 people and killed 2909 of them. These figures, which are far greater than those from all previous Ebola outbreaks  Read More »

White House Issues New Regulations for Dangerous Biological Research

NewYorkTimes: The Obama administration on Wednesday issued new guidelines intended to strengthen the oversight of federally funded biology research that could inadvertently produce bio-weapons. The new policy shifts the burden of finding and disclosing the dangerous aspects of research from the funding agency — usually the National Institutes of Health —  Read More »

CDC probing reports of paralysis in 9 Colorado children, including some with Enterovirus 68

TheWashingtonPost- Several children in Colorado, including some that have tested positive for the Enterovirus 68 respiratory illness, also reported neurological symptoms including muscle weakness and paralysis. That virus has been confirmed in the District of Columbia and all but 10 states, according to the Centers for Disease Control and Prevention, and it has  Read More »

Years of Preparation Pay Off with Ebola Diagnostic